Aug 3, 2026 08:31AM
Jul 27, 2026 04:26PM
May 29, 2026 04:49PM
May 15, 2026 12:36PM
Apr 16, 2026 04:36PM
Mar 26, 2026 04:42PM
Feb 17, 2026 12:43PM Form SCHEDULE 13G BridgeBio Pharma, Inc. Filed by: JANUS HENDERSON GROUP PLC
Nov 14, 2025 12:20PM
Jul 29, 2025 11:21AM
Feb 13, 2025 05:24PM
Nov 12, 2024 11:45AM
Oct 22, 2024 06:07PM
Feb 16, 2024 07:16PM
Feb 13, 2024 05:02PM Form SC 13G/A BridgeBio Pharma, Inc. Filed by: VANGUARD GROUP INC
Jan 29, 2024 05:27PM
Jan 23, 2024 10:16AM
Feb 14, 2023 04:39PM
Feb 9, 2023 11:18AM
Feb 8, 2023 10:31AM
Feb 1, 2023 06:13AM
Jun 13, 2022 08:20AM BridgeBio Pharma Inc. (BBIO) Shares Positive Phase 2b Data and Announces Pivotal Study Design for Phase 3 Trial of Encaleret in Autosomal Dominant Hypocalcemia Type 1
Feb 15, 2022 06:34AM
Feb 14, 2022 06:24PM
Feb 9, 2022 03:35PM
Feb 3, 2022 04:45PM
Feb 16, 2021 05:13PM
Feb 16, 2021 03:36PM
Feb 16, 2021 06:29AM Form SC 13G/A BridgeBio Pharma, Inc. Filed by: AMERICAN INTERNATIONAL GROUP, INC.
Feb 10, 2021 10:41AM
Feb 5, 2021 07:53AM
Feb 14, 2020 05:05PM
Feb 14, 2020 04:00PM
Feb 14, 2020 08:21AM
Jul 11, 2019 05:01PM

292,386 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All